Enrichment of cancer stem cells based on heterogeneity of invasiveness

Stem Cell Reviews and Reports

Volumn 5, Issue 1, 2009, Pages 66-71

  Yu, Shi cang ^a   Bian, Xiu wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Extracellular matrix; Invasiveness; Isolation; Migration

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL; BIOSYNTHESIS; CANCER INVASION; CANCER STEM CELL; CELL FREE SYSTEM; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLIOMA; HUMAN; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; PATHOLOGY; PROTEIN MICROARRAY; REVIEW;

ANIMALS; ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL-FREE SYSTEM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GLIOMA; GLYCOPROTEINS; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PEPTIDES; PROTEIN ARRAY ANALYSIS;

EID: 70349157505     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-008-9047-8     Document Type: Article

References (38)

1. Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111. doi:10.1038/35102167.
2. Polyak, K., & Hahn, W. C. (2006). Roots and stems: stem cells in cancer. Natural Medicines, 12, 296-300. doi:10.1038/nm1379.
3. Bao, S., Wu, Q., McLendon, R. E., et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature, 444, 756-760. doi:10.1038/nature05236.
4. Liu, G., Yuan, X., Zeng, Z., et al. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Molecular Cancer, 5, 67. doi:10.1186/1476-4598-5-67.
5. Eramo, A., Lotti, F., Sette, G., et al. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death & Differentiation, 15, 504-514. doi:10.1038/sj.cdd.4402283.
6. Van, S. A., van der Pol, M. A., Kok, A., et al. (2003). Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia. Haematologica, 88, 497-508.
7. Sheridan, C., Kishimoto, H., Fuchs, R. K., et al. (2006). CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Research, 8, R59. doi:10.1186/bcr1610.
8. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3, 730-737. doi:10.1038/nm0797-730.
9. Tirino, V., Desiderio, V., d,, 'Aquino, R., et al. (2008). Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One, 3, e3469. doi:10.1371/journal.pone.0003469.
10. Baba, T., Convery, P. A., Matsumura, N., et al. (2008). Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. doi:10.1038/onc.2008.374.
11. Beier, D., Hau, P., Proescholdt, M., et al. (2007). CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research, 67, 4010-4015. doi:10.1158/0008-5472.CAN-06-4180.
12. Ogden, A. T., Waziri, A. E., Lochhead, R. A., et al. (2008). Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery, 62, 505-514. doi:10.1227/01.neu.0000316019.28421.95.
13. Shmelkov, S. V., Butler, J. M., Hooper, A. T., et al. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. The Journal of Clinical Investigation, 118, 2111-2120.
14. Zheng, X., Shen, G., Yang, X., & Liu, W. (2007). Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Research, 67, 3691-3697. doi:10.1158/0008-5472.CAN-06-3912.
15. Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Research, 67, 4827-4233. doi:10.1158/0008-5472.CAN-06-3557.
16. Wang, J., Guo, L. P., & Chen, L. Z. (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research, 67, 3716-3724. doi:10.1158/0008-5472.CAN-06-4343.
17. Kondo, T., Setoguchi, T., & Taga, T. (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proceedings of the National Academy of Sciences of the United States of America, 101, 781-786. doi:10.1073/pnas.0307618100.
18. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005). Side population is enriched in tumorigenic, stem-Like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Research, 65, 6207-6219. doi:10.1158/0008-5472.CAN-05-0592.
19. Hirschmann Jax, C., Foster, A. E., Wulf, G. G., et al. (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 101, 14228-14233. doi:10.1073/pnas.0400067101.
20. Hadnagy, A., Gaboury, L., Beaulieu, R., & Balicki, D. (2006). SP analysis may be used to identify cancer stem cell populations. Experimental Cell Research, 312, 3701-3710. doi:10.1016/j.yexcr.2006.08.030.
21. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of Experimental Medicine, 183, 1797-1806. doi:10.1084/jem.183.4.1797.
22. Burkert, J., Otto, W. R., & Wright, N. A. (2008). Side populations of gastrointestinal cancers are not enriched in stem cells. The Journal of Pathology, 214, 564-573. doi:10.1002/path.2307.
23. Yuan, X., Curtin, J., Xiong, Y., et al. (2004). Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 23, 9392-9400. doi:10.1038/sj.onc.1208311.
24. Salmaggi, A., Boiardi, A., Gelati, M., et al. (2006). Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia, 54, 850-860. doi:10.1002/glia.20414.
25. Reynolds, B. A., & Weiss, S. (1996). Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Developments of Biological, 175, 1-13. doi:10.1006/dbio.1996.0090.
26. Yu, F., Yao, H., Zhu, P., et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123. doi:10.1016/j.cell.2007.10.054.
27. Li, H. Z., Yi, T. B., & Wu, Z. Y. (2008). Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BioMed Central Cancer, 8, 135. doi:10.1186/1471-2407-8-135.
28. Dean, M., Fojo, T., & Bates, S. (2005). Tumour stem cells and drug resistance. Nature Reviews Cancer, 5, 275-284. doi:10.1038/nrc1590.
29. Eramo, A., Ricci-Vitiani, L., Zeuner, A., et al. (2006). Chemotherapy resistance of glioblastoma stem cells. Cell Death & Differentiation, 13, 1238-1241. doi:10.1038/sj.cdd.4401872.
30. Ghods, A. J., Irvin, D., Liu, G., et al. (2007). Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells, 25, 1645-1653. doi:10.1634/stemcells.2006-0624.
31. Pellegatta, S., Poliani, P. L., Corno, D., et al. (2006). Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Research, 66, 10247-10252. doi:10.1158/0008-5472.CAN-06-2048.
32. Rak, J. (2006). Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis? Medical Hypotheses, 66, 601-604. doi:10.1016/j.mehy.2005.09.004.
33. Shen, R., Ye, Y., Chen, L., Yan, Q., Barsky, S. H., & Gao, J. X. (2008). Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One, 3, e1652. doi:10.1371/journal.pone.0001652.
34. Locke, M., Heywood, M., Fawell, S., & Mackenzie, I. C. (2005). Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Research, 65, 8944-8950. doi:10.1158/0008-5472.CAN-05-0931.
35. Yu, S. C., Ping, Y. F., Yi, L., et al. (2008). Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Letters, 265, 124-134. doi:10.1016/j.canlet.2008.02.010.
36. Lee, J., Kotliarova, S., Kotliarov, Y., et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9, 391-403. doi:10.1016/j.ccr.2006.03.030.
37. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005). Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Review Cancer, 5, 744-749. doi:10.1038/nrc1694.
38. Li, F., Tiede, B., Massagué, J., & Kang, Y. (2007). Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research, 17, 3-14. doi:10.1038/sj.cr.7310118.